The US Food and Drug Administration (FDA) has approved emergency use of 'Remdesivir', which is expected as a cure for Corona19 on the 1st (local time).
Remdesivir was originally developed by the American pharmaceutical company Gilead Sciences as an treatment for Ebola, but clinical trials involving inpatients of Corona19 resulted in positive results and attracted attention.
In a statement today, the FDA said that Remdecivir will be specifically designated for severely inpatient corona19 patients who require ventilators, etc., due to respiratory problems.
President Trump also shared the news at the White House with Gilead's Chief Executive Officer Daniel O'Day (CEO) and FDA Director Stephen Han.
FDA's approval for emergency use is a measure that can be taken while the study is underway, and is different from a full license.
However, it is possible to prescribe if the emergency use is approved.
Preliminary conclusions from research sponsored by the U.S. government found that Remdesivir reduced the recovery period by 31%, on average, about 4 days for Corona19 patients.
U.S. Food and Drug Administration approves emergency use of remedyvir as a treatment for corona19
2020-05-01T23:53:32.051Z
The U.S. Food and Drug Administration (FDA) approved emergency use of 'Remedyvir', which is expected as a treatment for corona19 on the 1st. Remdesivir was originally developed by the American pharmaceutical company Gilead Sciences as an treatment for Ebola, but clinical trials involving inpatients of Corona19 resulted in positive results and attracted attention.
Source: sbskr